1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 2: Clinical data commonly used as prognostic factors for the 25 patients with ALS
Clinical Data Patients with ALS Baseline 1-Year Follow-Up Subgroup Body mass index at MRI (± SD) 23.7 ± 2.7 24.0 ± 2.7 Familial transmission 2 SOD1 mutated 1 SOD1 mutated Site of onset 1 bulbar; 18 upper; 6 lower 1 bulbar; 12 upper; 6 lower Delay from first symptom to diagnosis, mo ± SD 9.9 ± 5.6 10.7 ± 6.0
Note:—SOD1 indicates SuperOxide Dismutase 1 gene.